✨ Free AI Report
Bio-Rad Laboratories, Inc.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Company Research Bio-Rad Laboratories, Inc.
Company Research

Bio-Rad Laboratories, Inc.: Business Overview, Financials & Competitive Analysis

Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics, developing instruments, reagents, and diagnostics for research institutions and clinical laboratories. The company operates tw...

Analyst-debate audio for Bio-Rad Laboratories, Inc.

AskCyborg analysts argue the bull and bear cases for Bio-Rad Laboratories, Inc. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
6/ 10Solid

Cyborg Score thesis

Financially stable but organically challenged; strong cash position enables M&A and buybacks, though near-term growth limited by...

Read the full analyst-debate transcript →
Industry Life Sciences Research & Clinical Diagnostics
4 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: November 2, 2026
AI-Generated Research
30+ Page Report

Get the Latest Bio-Rad Laboratories, Inc. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Bio-Rad Laboratories, Inc. Overview

Pro stress-test →

Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics, developing instruments, reagents, and diagnostics for research institutions and clinical laboratories. The company operates two complementary segments: Life Science Research, which provides tools for biological discovery, and Clinical Diagnostics, which serves hospitals and clinical labs with testing systems and quality controls.

Strategic Profile

Pro stress-test →

Bio-Rad is extending ddPCR systems into oncology, biopharma quality control and cell & gene therapy release testing. The company faces near-term headwinds with anticipated challenges in the biopharma market and among small biotech companies, with ongoing uncertainty in the Chinese market expected to persist into 2026, but maintains strategic focus on acquisitions and margin improvement.

Competitive Landscape

Pro stress-test →

Bio-Rad faces intense competition from large multinational corporations including Thermo Fisher Scientific, Danaher, and Abbott Laboratories, which have substantial resources and global reach that could pressure market share and pricing power. The company differentiates through specialized ddPCR technology and diagnostic automation, though competitive intensity in life sciences and diagnostics remains high.

Industry Context

Bio-Rad Laboratories, Inc. operates in Life Sciences Research & Clinical Diagnostics.

Key facts

Founded: 1952 · Headquarters: Hercules, US · Employees: 8,000+ · Revenue: $2.58B · Market cap: $4.45B

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Bio-Rad Laboratories, Inc..

  • ddPCR portfolio delivered mid-single-digit growth in Q4 2025 with strong QX700 instrument sales momentum; platform positioned as core long-term growth pillar
  • Process chromatography delivered more than 20% growth in 2025 from select therapeutics and vaccines, but business is inherently lumpy and concentrated
+2 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

  • February 2026Annual Form 10-K report filed with net sales of $2,583.2 million, up 0.7% year-over-year
  • February 20262026 guidance issued for 0.5%–1.5% currency-neutral revenue growth with Q1 declining low single digits before improving
  • +1 moreTrack every material event for Bio-Rad Laboratories, Inc. as it happens. Explore monitoring →
Get alerted when Bio-Rad Laboratories, Inc. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Compare Bio-Rad Laboratories, Inc. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Bio-Rad Laboratories, Inc. operates in Life Sciences Research & Clinical Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse Life Sciences Research & Clinical Diagnostics research →
NEW · MCP server

Ask your AI assistant about Bio-Rad Laboratories, Inc.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Bio-Rad Laboratories, Inc. and its top competitor on Cyborg Score”
“What did Bio-Rad Laboratories, Inc. do this quarter?”
“Is Bio-Rad Laboratories, Inc. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Bio-Rad Laboratories, Inc. do?+
Bio-Rad Laboratories is a global leader in life science research and clinical diagnostics, developing instruments, reagents, and diagnostics for research institutions and clinical laboratories. The company operates tw...
What is Bio-Rad Laboratories, Inc.'s Cyborg Score?+
Bio-Rad Laboratories, Inc. has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Bio-Rad Laboratories, Inc.'s main competitors?+
Named competitors include Thermo Fisher, Danaher, Abbott Diagnostics, Roche Diagnostics. The full competitive landscape is in the AskCyborg report.
How can I get the full Bio-Rad Laboratories, Inc. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Bio-Rad Laboratories, Inc. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Bio-Rad Laboratories, Inc. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual